Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Sell
46
CDXS Quote, Financials, Valuation and Earnings
Last price:
$1.65
Seasonality move
:
16.91%
Day range:
$1.63 - $1.69
52-week range:
$1.52 - $5.51
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.63x
P/B ratio:
3.84x
Volume:
2.2M
Avg. volume:
1.1M
1-year change:
-67.13%
Market cap:
$148.1M
Revenue:
$59.3M
EPS (TTM):
-$0.75
Analysts' Opinion
-
Consensus RatingCodexis, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 4 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $6.58, Codexis, Inc. has an estimated upside of 301.42% from its current price of $1.64.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $2.00 representing 100% downside risk from its current price of $1.64.
Fair Value
-
According to the consensus of 6 analysts, Codexis, Inc. has 301.42% upside to fair value with a price target of $6.58 per share.
CDXS vs. S&P 500
-
Over the past 5 trading days, Codexis, Inc. has underperformed the S&P 500 by -0.83% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Codexis, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Codexis, Inc. revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Codexis, Inc. reported revenues of $8.6M.
Earnings Growth
-
Codexis, Inc. has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Codexis, Inc. reported earnings per share of -$0.22.
Enterprise value:
157.6M
EV / Invested capital:
1.47x
Price / LTM sales:
2.63x
EV / EBIT:
--
EV / Revenue:
2.98x
PEG ratio (5yr expected):
-0.49x
EV / Free cash flow:
-2.56x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$37M
Return On Assets:
-46.46%
Net Income Margin (TTM):
-120.82%
Return On Equity:
-112.54%
Return On Invested Capital:
-54.85%
Operating Margin:
-220.31%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $74M | $64.4M | $52.9M | $12.8M | $8.6M | |
| Gross Profit | $49.8M | $44.1M | $37M | $7.3M | $4.8M | |
| Operating Income | -$65.2M | -$50.7M | -$59.6M | -$16.6M | -$18.9M | |
| EBITDA | -$54.5M | -$42.7M | -$51.6M | -$14.6M | -$16.9M | |
| Diluted EPS | -$1.21 | -$0.88 | -$0.75 | -$0.29 | -$0.22 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $174.1M | $146M | $103M | $112.9M | $76.2M | |
| Total Assets | $227.6M | $235.3M | $154.5M | $148.2M | $124M | |
| Current Liabilities | $33.5M | $31.9M | $38.4M | $35.1M | $18.5M | |
| Total Liabilities | $58.5M | $81.2M | $62.9M | $74.8M | $85.4M | |
| Total Equity | $169.1M | $154.1M | $91.5M | $73.4M | $38.5M | |
| Total Debt | $23M | $39.7M | $13.2M | $37.8M | $65.5M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$36.7M | -$44M | -$55.9M | -$13M | -$7.7M | |
| Cash From Investing | -$5.9M | -$53M | $14.9M | $1.5M | $6.4M | |
| Cash From Financing | $8.5M | $59.4M | $28.9M | $30.3M | -$111K | |
| Free Cash Flow | -$41.4M | -$46.1M | -$61.7M | -$14M | -$7.9M | |
CDXS
Sector
Market Cap
$148.1M
$28.2M
Price % of 52-Week High
29.79%
50.25%
Dividend Yield
0%
0%
Shareholder Yield
-10.99%
-1.54%
1-Year Price Total Return
-67.13%
-18.1%
Beta (5-Year)
2.468
0.516
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$1.66
200-day SMA
Sell
Level
$2.41
Bollinger Bands (100)
Sell
Level
1.82 - 2.74
Chaikin Money Flow
Sell
Level
-22.7M
20-day SMA
Sell
Level
$1.71
Relative Strength Index (RSI14)
Sell
Level
42.49
ADX Line
Sell
Level
13.73
Williams %R
Buy
Level
-88.5714
50-day SMA
Sell
Level
$1.94
MACD (12, 26)
Sell
Level
-0.07
25-day Aroon Oscillator
Buy
Level
40
On Balance Volume
Neutral
Level
2.7M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-2.7229)
Sell
CA Score
(Annual)
Level (-1.9718)
Buy
Beneish M-Score
(Annual)
Level (-3.1775)
Buy
Momentum Score
Level (3)
Sell
Ohlson Score
Level (3.4856)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Codexis, Inc. is an enzyme engineering company, which engages in the development and sale of therapeutics. It operates through the Performance Enzymes and Novel Biotherapeutics segments. The Performance Enzymes segment commercializes CodeEvolver protein engineering technology platform and products in the pharmaceuticals market. The Novel Biotherapeutics segment targets new opportunities to discover and improve biotherapeutic drug candidates. Its products include screening kits and Codex HiFi Hot Start DNA Polymerase. The company was founded in January 2002 and is headquartered in Redwood City, CA.
Stock Forecast FAQ
In the current month, CDXS has received 4 Buy ratings 2 Hold ratings, and 0 Sell ratings. The CDXS average analyst price target in the past 3 months is $6.58.
-
Where Will Codexis, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Codexis, Inc. share price will rise to $6.58 per share over the next 12 months.
-
What Do Analysts Say About Codexis, Inc.?
Analysts are divided on their view about Codexis, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Codexis, Inc. is a Sell and believe this share price will drop from its current level to $2.00.
-
What Is Codexis, Inc.'s Price Target?
The price target for Codexis, Inc. over the next 1-year time period is forecast to be $6.58 according to 6 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is CDXS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Codexis, Inc. is a Buy. 4 of 6 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of CDXS?
You can purchase shares of Codexis, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Codexis, Inc. shares.
-
What Is The Codexis, Inc. Share Price Today?
Codexis, Inc. was last trading at $1.65 per share. This represents the most recent stock quote for Codexis, Inc.. Yesterday, Codexis, Inc. closed at $1.64 per share.
-
How To Buy Codexis, Inc. Stock Online?
In order to purchase Codexis, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get CDXS Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CDXS
Sector
P/E ratio
--
23.92x
PEG ratio
-0.49x
-0.01x
P/B ratio
3.84x
1.83x
Price / LTM sales
2.63x
1.61x
Growth Metrics
CDXS
Sector
Revenue growth
-32.98%
4.6%
Earnings growth
24.15%
10.88%
Revenue (5-year growth)
-2.82%
6.46%
Earnings forecast
-$0.13
-$0.21
Profitability
CDXS
Sector
Profitability FY 2024
$38.2M
$3.5M
Return on invested capital
-54.85%
-31.84%
Return on assets
-46.46%
-27.96%
Return on equity
-112.54%
-37.63%
Earnings Date
Last Earnings Date
Nov
6
Next Earnings Date
Feb
26
Estimated Next Earnings Date
Feb
5
Balance Sheet
CDXS
Sector
Total cash
$59.2M
$26.3M
Short term investments
$54.2M
$25.7M
Total assets
$149M
$76.9M
Long term debt
$65.5M
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
69
GDXU alert for Dec 30
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is down 18.81% over the past day.
Sell
20
SMX alert for Dec 30
SMX (Security Matters) Plc [SMX] is down 27.67% over the past day.
Buy
63
GLTO alert for Dec 30
Galecto, Inc. [GLTO] is down 12.13% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
